Pharmacokinetics of Different CoQ10 Formulations

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions
Coenzyme Q10 Pharmacokinetics
Interventions
DIETARY_SUPPLEMENT

CoQ10

"Participants will be randomly and blindly assigned to receive a single dose (200 mg) of one of the preparations (treatments).~Fasting blood samples are taken at baseline (t=0) or pre-dose for CoQ10 baseline determination.~Participants receive treatment at time zero with a glass of water (\~ 125 mL), along with a standardized breakfast-provided immediately after the dose.~Capsules are administered as a single oral dose, with a wash-out period of at least 3-4 weeks between the two Coenzyme Q10 test products.~Capillary blood samples are collected at time points 0, 0.5, 1, 2, 3, 4,5, 6, 8, 10, 12, 24, 48- and 72-hours post-dose. A standardized lunch is provided after the 4hr blood sample, as well as a standardized dinner after the 8-h sample. Identical meals are served to all participants on each test day."

Trial Locations (1)

V3N 4S9

ISURA, Burnaby

All Listed Sponsors
collaborator

Isura

OTHER

lead

Factors Group of Nutritional Companies Inc.

INDUSTRY